Equine healthcare market was valued at $1,206.70 billion in 2020, and is projected to reach $2,328.90 billion by 2030, registering a CAGR of 6.80% from 2021 to 2030. Horses need proper care after a hard workout to help with cool-down and recovery. There are multiple areas to pay close attention to after a ride such as body temperature, respiration, muscle care, and leg condition. Equine healthcare helps to recognize the things when it gets bad for the health of the horses. In addition to properly feeding and exercising oneโs horse, other aspects of general care are needed to keep the horse healthy throughout his or her life. These include routine veterinary care for vaccinations, parasite control, and dental care; grooming and hoof care; and protection from the elements. Horses must be regularly monitored for the sign of illness that include lack of appetite, diarrhea, coughing, and sneezing, or discharge from the eyes or nose, loss of hair or itchy areas on the skin, lameness (such as not putting weight on a particular leg), and reluctance to move or head bobbing.
๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ :
The key players operating in the global equine healthcare market include Thermo Fisher Scientific (Affymetrix), Elanco Animal Health (Bayer Animal Health), Boehringer Ingelheim, Ceva Sante Animale, Land o Lakes(Purina Mills LLC), Equine Products UK Ltd, Merck & Co.(Merck Animal Health), Sanofi S.A. (Merial), Vetoquinol S.A., and Zoetis.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/request-sample/387
๐๐ผ๐๐ถ๐ฑ-๐ญ๐ต ๐ฆ๐ฐ๐ฒ๐ป๐ฎ๐ฟ๐ถ๐ผ:
The COVID-19 pandemic affected the equine healthcare industry in a negative way similar to various other domestic industries. Some governments mandated the closure of equine facilities to reduce the spread of the virus and minimize risks of injury while others delegated responsibility to equine enterprise owners and managers. The complete closure of equine facilities has been especially damaging, as these operations bear significant ongoing expenses with no source of revenue. Increasing unemployment rates in the initial days lead to increase in problems associated with equine welfare.
๐
๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ https://www.alliedmarketresearch.com/purchase-enquiry/387
On the basis of products type, the market is categorized into drug, vaccines, and medicated feed additives. The drug segment dominated the global market in 2020, and is anticipated to continue this trend during the forecast period. The key factors, such as rise in demand for pet insurance, surge in awareness toward effective & advanced drugs and vaccines, and rise in number of cases of equine diseases may lead to increase in hospital admissions. Launch of effective products, which are tested under clinical trials by companies, ensures better therapeutic outcomes.
On the basis of disease, the market is segregated into influenza, tetanus, equine herpes virus, and others. At present, the others segment accounts for a majority of the market share, owing to rise in prevalence of equine diseases in both developed as well as developing countries and surge in demand for pet insurance that would help the segment generate higher revenue shares in the coming years.
On the basis of distribution channel, the market is segregated into veterinary hospitals and clinics and retail pharmacies and drug stores. At present, the retail pharmacies and drug stores segment accounts for the majority of market share, owing to rise in prevalence of equine diseases in both developed as well as developing countries and growing awareness among the population about the importance and benefits of horses healthcare.
๐๐๐ ๐
๐๐๐๐๐๐๐ ๐๐
๐๐๐ ๐๐๐๐๐
- By product type, the drugs segment was the highest contributor to the market, with $788.80 million in 2020, and is estimated to reach $1,515.50 million by 2030, at a CAGR of 6.70%.
- By diseases, the others segment was the highest contributor to the market, with $508.20 million in 2020, and is estimated to reach $908.80 million by 2030, at a CAGR of 5.90%.
- By distribution channel, the retail pharmacies and drug stores segment was the highest contributor to the market, with $693.60 million in 2020, and is estimated to reach $1,366.60 million by 2030, at a CAGR of 7.00%.
- North America is expected to be the fastest growing region, registering a CAGR of 5.90% during the forecast period.
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.